Dermapharm Holding SE (LON:0A5J)

Dermapharm Holding SE Statistics

Total Valuation

LON:0A5J has a market cap or net worth of GBP 1.73 billion. The enterprise value is 2.48 billion.

Market Cap	1.73B
Enterprise Value	2.48B

Important Dates

The next estimated earnings date is Tuesday, March 17, 2026.

Earnings Date	Mar 17, 2026
Ex-Dividend Date	Jun 27, 2025

Share Statistics

Current Share Class	53.84M
Shares Outstanding	n/a
Shares Change (YoY)	-0.14%
Shares Change (QoQ)	+1.51%
Owned by Insiders (%)	6.79%
Owned by Institutions (%)	11.91%
Float	7.77M

Valuation Ratios

The trailing PE ratio is 17.09 and the forward PE ratio is 15.34.

PE Ratio	17.09
Forward PE	15.34
PS Ratio	1.69
PB Ratio	3.07
P/TBV Ratio	n/a
P/FCF Ratio	12.06
P/OCF Ratio	9.60
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.77, with an EV/FCF ratio of 17.29.

EV / Earnings	24.50
EV / Sales	2.43
EV / EBITDA	10.77
EV / EBIT	12.34
EV / FCF	17.29

Financial Position

The company has a current ratio of 2.20, with a Debt / Equity ratio of 1.56.

Current Ratio	2.20
Quick Ratio	0.95
Debt / Equity	1.56
Debt / EBITDA	3.84
Debt / FCF	6.15
Interest Coverage	4.40

Financial Efficiency

Return on equity (ROE) is 18.50% and return on invested capital (ROIC) is 10.31%.

Return on Equity (ROE)	18.50%
Return on Assets (ROA)	6.77%
Return on Invested Capital (ROIC)	10.31%
Return on Capital Employed (ROCE)	12.59%
Weighted Average Cost of Capital (WACC)	7.87%
Revenue Per Employee	283,897
Profits Per Employee	28,055
Employee Count	3,551
Asset Turnover	0.55
Inventory Turnover	1.22

Taxes

In the past 12 months, LON:0A5J has paid 50.33 million in taxes.

Income Tax	50.33M
Effective Tax Rate	33.54%

Stock Price Statistics

The stock price has decreased by -4.78% in the last 52 weeks. The beta is 1.07, so LON:0A5J's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	-4.78%
50-Day Moving Average	37.10
200-Day Moving Average	35.00
Relative Strength Index (RSI)	57.50
Average Volume (20 Days)	5,759

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0A5J had revenue of GBP 1.02 billion and earned 101.28 million in profits. Earnings per share was 1.88.

Revenue	1.02B
Gross Profit	659.11M
Operating Income	200.55M
Pretax Income	150.05M
Net Income	101.28M
EBITDA	224.39M
EBIT	200.55M
Earnings Per Share (EPS)	1.88

Balance Sheet

The company has 127.94 million in cash and 882.40 million in debt, with a net cash position of -754.46 million.

Cash & Cash Equivalents	127.94M
Total Debt	882.40M
Net Cash	-754.46M
Net Cash Per Share	n/a
Equity (Book Value)	564.17M
Book Value Per Share	10.42
Working Capital	306.23M

Cash Flow

In the last 12 months, operating cash flow was 180.25 million and capital expenditures -36.76 million, giving a free cash flow of 143.49 million.

Operating Cash Flow	180.25M
Capital Expenditures	-36.76M
Free Cash Flow	143.49M
FCF Per Share	n/a

Margins

Gross margin is 64.31%, with operating and profit margins of 19.57% and 9.88%.

Gross Margin	64.31%
Operating Margin	19.57%
Pretax Margin	14.64%
Profit Margin	9.88%
EBITDA Margin	21.89%
EBIT Margin	19.57%
FCF Margin	14.00%

Dividends & Yields

This stock pays an annual dividend of 0.77, which amounts to a dividend yield of 2.13%.

Dividend Per Share	0.77
Dividend Yield	2.13%
Dividend Growth (YoY)	3.06%
Years of Dividend Growth	1
Payout Ratio	41.76%
Buyback Yield	0.14%
Shareholder Yield	2.27%
Earnings Yield	5.85%
FCF Yield	8.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0A5J has an Altman Z-Score of 2.22 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.22
Piotroski F-Score	7